Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Feb;42(1):62-4.
doi: 10.1016/j.diabet.2015.08.006. Epub 2015 Oct 9.

Weight loss at a high cost: Orlistat-induced late-onset severe kidney disease

B Buysschaert  1 , S Aydin  2 , J Morelle  3 , M P Hermans  4 , M Jadoul  3 , N Demoulin  5
Affiliations
Case Reports

Weight loss at a high cost: Orlistat-induced late-onset severe kidney disease

B Buysschaert et al. Diabetes Metab. 2016 Feb.

Abstract

Aim: This report describes a case of kidney failure secondary to orlistat, a lipase inhibitor commonly used in the treatment of obesity.

Case report: An 80-year-old man with type 2 diabetes who was being treated with orlistat developed rapidly progressive kidney failure. Low-grade albuminuria argued against diabetic nephropathy. Renal biopsy showed tubulointerstitial nephritis associated with numerous calcium oxalate crystals. Enteric hyperoxaluria was attributed to the orlistat treatment. The latter was stopped and the patient received calcium supplements. Six months after orlistat withdrawal, oxaluria was normalized and kidney function stabilized.

Conclusion: Oxalate nephropathy may result from hyperoxaluria secondary to orlistat treatment. This suggests that kidney function and oxaluria be closely monitored in patients taking orlistat.

Keywords: Hyperoxaluria; Orlistat; Oxalate nephropathy.

PubMed Disclaimer

Publication types

LinkOut - more resources